Medpace
MEDP
77 hedge funds and large institutions have $197M invested in Medpace in 2017 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 26 increasing their positions, 20 reducing their positions, and 21 closing their positions.
30% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 20
24% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 21
1.57% less ownership
Funds ownership: 17.83% → 16.25% (-1.6%)
3% less funds holding
Funds holding: 79 → 77 (-2)
25% less capital invested
Capital invested by funds: $262M → $197M (-$64.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$18.8M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$12.2M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$10.7M |
| 4 |
HM
HealthCor Management
New York
|
+$8.88M |
| 5 |
BCA
Bernzott Capital Advisors
Camarillo,
California
|
+$7.94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$15.8M |
| 2 |
BAMCO Inc
New York
|
-$15.2M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$12.5M |
| 4 |
FA
Friess Associates
Greenville,
Delaware
|
-$9.25M |
| 5 |
O
OppenheimerFunds
New York
|
-$9.19M |
MEDP Hedge Fund Activity: Q1 2017 in Review
77 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q1 2017, worth a combined $197M — down 25% from $262M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new MEDP positions and 21 closed out — a net gain of 5 holders — while 26 added to existing stakes and 20 trimmed.
The largest buyer was BlackRock, adding an estimated $18.8M. The largest seller was Fidelity Investments, cutting an estimated $15.8M.
- 77 institutional investors held Medpace (MEDP) as of Q1 2017, down from 79 in Q4 2016.
- Funds reported $197M of Medpace stock for Q1 2017, down 25% quarter-over-quarter.
- 26 funds opened new Medpace positions in Q1 2017 and 21 closed out, a net change of +5 holders.
- The largest Medpace buyer in Q1 2017 was BlackRock, an estimated $18.8M added.
- The largest Medpace seller in Q1 2017 was Fidelity Investments, an estimated $15.8M sold.
Based on aggregated 13F filings for Q1 2017.